Page 7 - Dme L News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dme l. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dme L Today - Breaking & Trending Today
The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy. ....
Experts wrap up their discussion by highlighting key takeaways on the treatment of retinal diseases with anti-vascular endothelial growth factor (Anti-VEGF) therapies. ....
Torx ® Software Limited has announced the release of Torx 2.0, extending the platform’s scientific reach and capabilities to deliver unrivalled seamless integration across the drug discovery Design-Make-Test-Analyze (DMTA) cycle. ....
With approval, aflibercept 8 mg becomes the first and only treatment approved in wAMD and DME for immediate dosing at 8-week and up to 16-week intervals following 3 initial monthly doses. ....
Experts discuss the recent PULSAR and PHOTON studies with high dose aflibercept (8mg) and how they educate patients about this treatment approach. ....